Overview

Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Selegiline is superior to placebo in improving psychological and physical functioning in patients with Borderline Personality Disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Mood and Anxiety Research, Inc
Treatments:
Selegiline